Press release
Rituximab Biosimilars Market 2023 - Estimated Yield, Growth Analysis, Demand Forecast And Future Prospects
Rituximab Biosimilars Market
As per the rituximab biosimilars market report by The Business Research Company, the rising prevalence of non-Hodgkin's lymphoma (NHL) is predicted to contribute to the growth of the rituximab biosimilars market. Non-Hodgkin's lymphoma, or lymphoma, is cancer that starts in white blood cells, and lymphocytes that are part of the body's immune system.
The global rituximab biosimilars market grew from $2.05 billion in 2022 to $2.35 billion in 2023 at a compound annual growth rate (CAGR) of 14.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The rituximab biosimilars market is expected to grow from $3.84 billion in 2027 at a CAGR of 13.1%.
Read More On The Rituximab Biosimilars Market Report Here:
https://www.thebusinessresearchcompany.com/report/rituximab-biosimilar-global-market-report
Major competitors in the rituximab biosimilars market include Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., and Celltrion Healthcare Co. Ltd., Sandoz International GmbH, Reliance Life Sciences, C.H. Boehringer Sohn AG & Co. KG, BioXpress Therapeutics SA, and Intas Biopharmaceuticals Ltd.
The rituximab biosimilars market is segmented -
• By Application: Non-Hodgkin's Lymphoma, Chronic Lymhocytic Leukemia, Rheumatoid Arthritis, Other Applications
• By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Direct Distribution Channels
• By Route Of Administration: Subcutaneous, Intravenous, Molecular Type
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America is the largest region in the rituximab biosimilars market.
Check Out Buying Options For The Rituximab Biosimilars Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3430
Rituximab biosimilar refers to a chimeric monoclonal antibody that is directed against the immune system's B cell-specific protein CD20. Rituximab kills B cells, making it useful for treating conditions where there are too many, too active, or otherwise abnormal B cells.
The Table Of Content For The Rituximab Biosimilars Market Include:
1. Executive Summary
2. Rituximab Biosimilars Market Characteristics
3. Rituximab Biosimilars Market Trends And Strategies
4. Rituximab Biosimilars Market - Macro Economic Scenario
5. Rituximab Biosimilars Market Size And Growth
6. Rituximab Biosimilars Market Segmentation
……
27. Rituximab Biosimilars Market Competitive Landscape And Company Profiles
28. Rituximab Biosimilars Pipeline Analysis
29. Key Mergers And Acquisitions In The Rituximab Biosimilars Market
30. Rituximab Biosimilars Market Future Outlook and Potential Analysis
31. Appendix
The "Global Rituximab Biosimilars Market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rituximab Biosimilars Market 2023 - Estimated Yield, Growth Analysis, Demand Forecast And Future Prospects here
News-ID: 2878052 • Views: …
More Releases from The Business research company
Tretten Or Novothirteen Market Forecast 2025-2034: Comprehensive Analysis And Gr …
"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Current Tretten Or Novothirteen Market Size and Its Estimated Growth Rate?
In recent years, the tretten or novothirteen market has expanded at a rate of XX (HCAGR). It's projected to increase from $XX million in 2024 to $XX million in 2025, reflecting a compound annual growth rate (CAGR) of…
Global TICE BCG Market Analysis 2025-2030: Growth Drivers, Challenges, And Oppor …
"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the TICE BCG Market Size Expected to Be by 2034?
The scale of the TICE BCG market has amplified by XX (HCAGR) in the past few years. It is projected to expand from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR)…
Palynziq Industry Report 2025-2034: Market Dynamics, Drivers, And Forecasts
"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Palynziq Market?
The market size of Palynziq has seen a rise of XX(HCAGR) in the last few years. The projected growth is from $XX million in 2024 to $XX million in 2025, with the compound annual growth rate (CAGR) set at XX%. The historic surge…
Obizur Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunitie …
"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Current Obizur Market Size and Its Estimated Growth Rate?
The market size of obizur has seen a notable growth, with an HCAGR of XX in recent years. The market is projected to escalate from a valuation of $XX million in 2024 to $XX million in 2025, recording a compound…
More Releases for Rituximab
Rituxan (rituximab) Drug Market Trends, Demand Service, Share, Industry Size, Gr …
LOS ANGELES, United States: QY Research offers an encyclopedic study of the global Rituxan (rituximab) Drug market with holistic insights into vital factors and aspects that impact future market growth. The global Rituxan (rituximab) Drug market has been analyzed for the forecast period 2022-2028 and historical period 2017-2021. In order to help players to gain comprehensive understanding of the global Rituxan (rituximab) Drug market and its critical dynamics, the research study…
2022 Rituximab Biosimilars Market Report, Overview, Size, Trends, Growth And For …
'Rituximab Biosimilars Global Market Report 2022 -Market Size, Trends, And Global Forecast 2022-2026' by The Business Research Company is the most comprehensive report available on this market, with analysis of the market's historic and forecast growth, drivers and restraints causing it, and highlights of the opportunities that companies in the industry can take on. The Rituximab Biosimilars market research report helps gain a truly global perspective of the Rituximab Biosimilars…
Global Rituximab Biosimilars Market 2021 : SWOT Analysis of Key Driving Factors …
Get up to 33% off on ALL market research reports at The Business Research Company's holiday sale; buy now!
https://www.thebusinessresearchcompany.com/global-market-reports
‘Rituximab Biosimilars Global Market Report 2021 – COVID-19 Growth And Change’ by The Business Research Company is the most comprehensive report available on this market, with analysis of the market’s historic and forecast growth, drivers and restraints causing this, and highlights of the opportunities that companies in the industry can take on.…
Complete Analysis On Rituximab Biosimilars Market | Global Key Trends Analysis, …
The Business Research Company offers "Rituximab Biosimilars Global Market Report 2021: COVID-19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It…
Rituximab Biosimilars Market Share, Growth Insights, Regional Overview, Competit …
The rituximab biosimilar market reached a value of nearly $1,602.1 million in 2020, having increased at a compound annual growth rate (CAGR) of 67.9% since 2015. The market is expected to grow from $1,602.1 million in 2020 to $3,474.2 million in 2025 at a rate of 16.7%. The market is then expected to grow at a CAGR of 10.5% from 2025 and reach $5,723.6 million in 2030.
The Business…
Rituximab Drug Market Primary Research, Secondary Research, Product Research, Si …
QY Research has published a latest and most trending report on Rituximab Drug Market offers detailed value chain assessment, comprehensive study on market dynamics including drivers, restraints and opportunities, recent trends, and industry performance analysis. Furthermore, it digs deep into critical aspects of key subjects such as market competition, regional growth, and market segmentation so that readers could gain a sound understanding of the global Rituximab Drug market.
The global Rituximab…
